SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against STAAR Surgical Company and Its Board of Directors and a Lead Plaintiff Deadline of September 8, 2014 -- STAA


NEW YORK, July 29, 2014 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased STAAR Surgical Company ("STAAR" or the "Company") (Nasdaq:STAA) securities between February 27, 2013 and June 30, 2014.

For more information, click here: http://zlk.9nl.com/staar-surgical-staa.

The complaint alleges that the Company made false and/or misleading statements and/or failed to disclose that the Company's Monrovia Facility: (a) lacked adequate methodologies and facilities for the manufacture, packing, storage and installation of the Company's implantable lenses; (b) lacked adequate procedures for documenting complaints, sterility testing, and maintining required records; and (c) as a result, the Monrovia Facility was not in conformity with current good manufacturing practice requirements at all relevant times.

On June 30, 2013, the FDA publicly released a Warning Letter following an inspection of the Monrovia Facility; the letter cited several regulatory violations at the facility and threatened regulatory action.

If you suffered a loss in STAAR you have until September 8, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/staar-surgical-staa.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.



            

Contact Data